Decreased Mammography in Breast Cancer Survivors

Decreased Mammography in Breast Cancer Survivors

Surveillance mammography has decreased over the last decade and a half. A study of 141,672 breast cancer survivors recently published in the Journal of the National Comprehensive Cancer Network (JNCCN), reveals that annual mammograms among breast cancer survivors declined from 74.1% to 67.1% in the 12 years between 2004 and 2016. All of those included…

Read More

COVID-Delayed Screenings Increase Late-Stage Breast Cancer Diagnoses

COVID-Delayed Screenings Increase Late-Stage Breast Cancer Diagnoses

The National Cancer Institute, in June 2020, expressed fears that declines in cancer screenings and delays in treatment due to the COVID-19 pandemic could contribute to an increase in rates of advanced cancer diagnoses and deaths through 2030. A recent study was led by Jade Zifei Zhou, MD, Ph.D., a hematology/oncology fellow at Moores Cancer…

Read More

Wide Variation in Imaging Prices

Wide Variation in Imaging Prices article

Revenue — it’s all over the news right now — from the No Surprises Act to the Hospital Price Transparency rule. Pricing for some “shoppable” radiology services varies significantly from one facility to another. The Hospital Price Transparency rule went into effect on January 1, 2021. The rule requires hospitals to provide “clear, accessible pricing…

Read More

Out-of-Pocket Costs Decrease Subsequent Breast Cancer Screenings

Out-of-Pocket Costs Decrease Subsequent Breast Cancer Screenings

A recent study, published in the Journal of the American College of Radiology, found that women who experienced out-of-pocket costs for their first screening mammogram were much less likely to have subsequent breast cancer screenings. Researchers wanted to know how out-of-pocket expenses for breast cancer screening impacted women and their decisions to continue mammography and…

Read More

PET Scans Help Decisions In ER And Breast Cancer

PET Scans Help Decisions In ER + Breast Cancer

A study has found 100% accuracy for subsequent outcomes with hormonal therapy A small prospective study showed that PET imaging of the progesterone receptor (PgR) response to an estradiol challenge the usual predicted breast cancer response to hormonal therapy. PET with a progestin-analog tracer showed increased PgR levels, indicative of functional estrogen receptors (ERs), in…

Read More